Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies

por Bao, Y, Ng, K, Wolpin, B M, Michaud, D S, Giovannucci, E, Fuchs, C S
Publicado 2010

Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification

por Gilbert, J. W., Wolpin, B., Clancy, T., Wang, J., Mamon, H., Shinagare, A. B., Jagannathan, J., Rosenthal, M.
Publicado en Ann Oncol (2017)

Reply to the letter to the editor ‘Borderline resectable pancreatic cancer: an evolving concept’ by Petrucciani et al.

por Gilbert, J. W., Wolpin, B., Clancy, T., Wang, J., Mamon, H., Shinagare, A. B., Jagannathan, J., Rosenthal, M.
Publicado en Ann Oncol (2017)

Nut consumption and risk of pancreatic cancer in women

por Bao, Y, Hu, F B, Giovannucci, E L, Wolpin, B M, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2013

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

por Ng, K, Wolpin, B M, Meyerhardt, J A, Wu, K, Chan, A T, Hollis, B W, Giovannucci, E L, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2009

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

por Ng, K, Wolpin, B M, Meyerhardt, J A, Wu, K, Chan, A T, Hollis, B W, Giovannucci, E L, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2010

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

por Wolpin, B M, Michaud, D S, Giovannucci, E L, Schernhammer, E S, Stampfer, M J, Manson, J E, Cochrane, B B, Rohan, T E, Ma, J, Pollak, M N, Fuchs, C S
Publicado 2007

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma

por Chan, J. A., Blaszkowsky, L. S., Enzinger, P. C., Ryan, D. P., Abrams, T. A., Zhu, A. X., Temel, J. S., Schrag, D., Bhargava, P., Meyerhardt, J. A., Wolpin, B. M., Fidias, P., Zheng, H., Florio, S., Regan, E., Fuchs, C. S.
Publicado 2011

Plasma inflammatory cytokines and survival of pancreatic cancer patients

por Babic, A., Schnure, N., Neupane, N. P., Zaman, M. M., Rifai, N., Welch, M. W., Brais, L. K., Rubinson, D. A., Morales-Oyarvide, V., Yuan, C., Zhang, S., Poole, E. M., Wolpin, B. M., Kulke, M. H., Barbie, D. A., Wong, K., Fuchs, C. S., Ng, K.
Publicado en Clin Transl Gastroenterol (2018)

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer(†)

por Wolpin, B. M., O'Reilly, E. M., Ko, Y. J., Blaszkowsky, L. S., Rarick, M., Rocha-Lima, C. M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., Hartford, A., Morrison, K., Jackson, L., Vincent, M., Reyno, L., Hidalgo, M.
Publicado 2013

Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies

por Genkinger, J. M., Kitahara, C. M., Bernstein, L., Berrington de Gonzalez, A., Brotzman, M., Elena, J. W., Giles, G. G., Hartge, P., Singh, P. N., Stolzenberg-Solomon, R. Z., Weiderpass, E., Adami, H.-O., Anderson, K. E., Beane-Freeman, L. E., Buring, J. E., Fraser, G. E., Fuchs, C. S., Gapstur, S. M., Gaziano, J. M., Helzlsouer, K. J., Lacey, J. V., Linet, M. S., Liu, J. J., Park, Y., Peters, U., Purdue, M. P., Robien, K., Schairer, C., Sesso, H. D., Visvanathan, K., White, E., Wolk, A., Wolpin, B. M., Zeleniuch-Jacquotte, A., Jacobs, E. J.
Publicado en Ann Oncol (2015)